{"id":"https://openalex.org/W2013409897","doi":"https://doi.org/10.1016/j.ejphar.2015.03.070","title":"Animal models of Parkinson\u05f3s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535)","display_name":"Animal models of Parkinson\u05f3s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535)","publication_year":2015,"publication_date":"2015-05-02","ids":{"openalex":"https://openalex.org/W2013409897","doi":"https://doi.org/10.1016/j.ejphar.2015.03.070","mag":"2013409897","pmid":"https://pubmed.ncbi.nlm.nih.gov/25936513"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejphar.2015.03.070","doi":"https://doi.org/10.1016/j.ejphar.2015.03.070","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2015.03.070","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070581688","display_name":"Maria Antonietta Stasi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maria Antonietta Stasi","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy. Electronic address: mariaantonietta.stasi@sigma-tau.it","Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy. Electronic address: mariaantonietta.stasi@sigma-tau.it","institution_ids":["https://openalex.org/I4210131844"]},{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023892631","display_name":"Patrizia Minetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Minetti","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085945009","display_name":"Katia Lombardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Katia Lombardo","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070267335","display_name":"Teresa Riccioni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Teresa Riccioni","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060180551","display_name":"Antonio Caprioli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Caprioli","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052247594","display_name":"Mario Vertechy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Vertechy","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040129095","display_name":"Stefano Di Serio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Di Serio","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035126613","display_name":"Silvia Pace","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Pace","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045815002","display_name":"Franco Borsini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Franco Borsini","raw_affiliation_strings":["Research & Development Area, Sigma-tau, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Area, Sigma-tau, Italy","institution_ids":["https://openalex.org/I4210131844"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070581688"],"corresponding_institution_ids":["https://openalex.org/I4210131844"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":0.214,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.53722353,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"761","issue":null,"first_page":"353","last_page":"361"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.3508000075817108,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor-antagonist","display_name":"adenosine A2A receptor antagonists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.8840000033378601},{"id":"https://openalex.org/keywords/non-dopaminergic-therapy","display_name":"non-dopaminergic therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/haloperidol-induced-catalepsy","display_name":"haloperidol-induced catalepsy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9139999747276306},{"id":"https://openalex.org/keywords/motor-activity","display_name":"motor activity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5809999704360962},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.7529493570327759},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7104417681694031},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.575127124786377},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5313188433647156},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5220962762832642},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5180859565734863},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.508424699306488},{"id":"https://openalex.org/C2778491162","wikidata":"https://www.wikidata.org/wiki/Q3063865","display_name":"Adenosine A2A receptor","level":5,"score":0.4929370880126953},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48189860582351685},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.40465426445007324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3763847053050995},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3471300005912781},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.34463685750961304},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25837332010269165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24072283506393433},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2228626310825348},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20640778541564941},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001479","descriptor_name":"Basal Ganglia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001479","descriptor_name":"Basal Ganglia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001479","descriptor_name":"Basal Ganglia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D043705","descriptor_name":"Receptor, Adenosine A2A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D043705","descriptor_name":"Receptor, Adenosine A2A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D043705","descriptor_name":"Receptor, Adenosine A2A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejphar.2015.03.070","doi":"https://doi.org/10.1016/j.ejphar.2015.03.070","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2015.03.070","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:25936513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25936513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1526596922","https://openalex.org/W1968560756","https://openalex.org/W1969321376","https://openalex.org/W1969782593","https://openalex.org/W1969801566","https://openalex.org/W1970073512","https://openalex.org/W1978927254","https://openalex.org/W1982734210","https://openalex.org/W1987380827","https://openalex.org/W1992100298","https://openalex.org/W1993614295","https://openalex.org/W1994975310","https://openalex.org/W2000939164","https://openalex.org/W2002669946","https://openalex.org/W2010129540","https://openalex.org/W2010916577","https://openalex.org/W2025284540","https://openalex.org/W2033564079","https://openalex.org/W2035957340","https://openalex.org/W2039647211","https://openalex.org/W2040227196","https://openalex.org/W2040473339","https://openalex.org/W2043505681","https://openalex.org/W2043598942","https://openalex.org/W2046812985","https://openalex.org/W2056890984","https://openalex.org/W2059577220","https://openalex.org/W2062214351","https://openalex.org/W2063130255","https://openalex.org/W2074631079","https://openalex.org/W2079155685","https://openalex.org/W2081714450","https://openalex.org/W2091163062","https://openalex.org/W2105840785","https://openalex.org/W2119450744","https://openalex.org/W2120634420","https://openalex.org/W2135281382","https://openalex.org/W2163338752","https://openalex.org/W2168910111","https://openalex.org/W2419155400","https://openalex.org/W4406066038"],"related_works":["https://openalex.org/W1978927254","https://openalex.org/W2039647211","https://openalex.org/W2025284540","https://openalex.org/W2010916577","https://openalex.org/W2010129540","https://openalex.org/W4407973698","https://openalex.org/W2037673105","https://openalex.org/W2163338752","https://openalex.org/W2416708726","https://openalex.org/W1992289692"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}